Company Information

Company Daiichi Sankyo Co. Ltd.
www.daiichisankyo.com
Type:
Company
Country:
Japan
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Publicly Listed
Global Compact Status:
Active
Participant Since
12 April 2012
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2025

Financial Information


Affiliated Subsidiaries

Country Company Name
Spain Daiichi Sankyo EspaƱa, S.A.U.
Brazil Daiichi Sankyo Brasil Farmaceutica

Communication On Progress

Published On Title Level/Status
30-Jun-2024 2024 Communication on Progress Submitted
29-Nov-2023 2023 Communication on Progress Submitted
23-Dec-2022 Daiichi Sankyo Group Value Report 2022 Advanced
25-Dec-2021 Communication on Progress Advanced
25-Dec-2020 Daiichi Sankyo Group Value Report 2020 Advanced
26-Dec-2019 Daiichi Sankyo Group Value Report 2019 Advanced
26-Dec-2018 Daiichi Sankyo Group Value Report 2018 Advanced
26-Dec-2017 Communication on Progress Advanced
26-Dec-2016 Communication on Progress Advanced
24-Dec-2015 Communication on Progress Advanced
25-Dec-2014 Value Report 2014 Advanced
26-Dec-2013 Value Report 2013 Advanced
25-Feb-2013 Communication on Progress Advanced

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.